← FDA Drug Approvals (Drugs@FDA)

GABAPENTIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HUMANWELL · Approved 2024-02-26

Drug application

FDA Application #

ANDA216252

Application type

Abbreviated New Drug Application (Generic)

Brand name

GABAPENTIN

Generic name

GABAPENTIN

Active ingredients

GABAPENTIN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

HUMANWELL

Manufacturer

Epic Pharma, LLC

First approval

2024-02-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown